NCT00322387View on ClinicalTrials.gov

Mobilization of Stem Cells With Plerixafor, Chemotherapy and G-CSF in Multiple Myeloma or Non-Hodgkin's Lymphoma Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions
Lymphoma, Non-HodgkinMultiple Myeloma
Interventions
DRUG

G-CSF and plerixafor

G-CSF and plerixafor were administered as described in the treatment arms.

Trial Locations (5)

Unknown

City of Hope National Medical Center, Duarte

Indiana Blood and Marrow Transplantation, Beech Grove

University of Rochester Medical Center, Rochester

Oregon Health and Science University, Portland

Fred Hutchinson Cancer Research Center, Seattle

All Listed Sponsors
lead

Genzyme, a Sanofi Company

INDUSTRY

NCT00322387 - Mobilization of Stem Cells With Plerixafor, Chemotherapy and G-CSF in Multiple Myeloma or Non-Hodgkin's Lymphoma Patients | Biotech Hunter | Biotech Hunter